New eye drug shows promise for blinding diseases
Disease control
Completed
This study tested a new eye injection called EYE103 in people with diabetic macular edema (DME) or wet age-related macular degeneration (NVAMD). The goal was to check safety and see if it helps improve vision. About 33 people took part, and the study looked at side effects and vi…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC